share_log

羚锐制药(600285.SH)发前三季业绩,净利润5.74亿元,同比增长23.10%

Henan Lingrui Pharmaceutical (600285.SH) released its performance for the first three quarters, with a net income of 0.574 billion yuan, a year-on-year increase of 23.10%.

Zhitong Finance ·  Oct 29, 2024 16:37

Henan Lingrui Pharmaceutical (600285.SH) released the report for the first three quarters of 2024, during which the company achieved revenue...

Zhixin Finance and Economics APP News, Henan Lingrui Pharmaceutical (600285.SH) released the report for the first three quarters of 2024. During the reporting period, the company achieved revenue of 2.759 billion yuan, a year-on-year increase of 10.07%; net income attributable to shareholders of the listed company was 0.574 billion yuan, a year-on-year increase of 23.10%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.541 billion yuan, a year-on-year increase of 22.54%; basic earnings per share was 1.024 yuan per share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment